Andrew J Armstrong

104PUBLICATIONS
362CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (104)

|Sep 26, 2026
External validation of the NADIR model for early prostate-specific antigen response prediction in enzalutamide-treated metastatic hormone-sensitive prostate cancer: An analysis of the ARCHES trial.

|Sep 05, 2026
Association between smoking, tumor genetics, and outcomes in men with metastatic prostate cancer.

|Aug 21, 2026
Successful cabazitaxel desensitization after severe taxane hypersensitivity reactions: a brief report.

|Aug 05, 2026
Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer.

|Jul 10, 2026
Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer.

|May 26, 2026
Genetic ancestry-concordant ceramide metabolism and response to androgen receptor pathway inhibition in metastatic castration-resistant prostate cancer.

Pageof 18

Frequent Collaborators

16 joint publications

Rana R McKay

15 joint publications

Daniel J George

15 joint publications

Susan Halabi

14 joint publications

Michael J Morris